Health Care · S&P 500 · data as of 2026-10-05
CNC stock analysis: Centene Centene (CNC) is an S&P 500 company in Managed Health Care. It grades weakest on profitability.
The model's view of CNC · subscribers Where CNC ranks among the 1,500 U.S. stocks the model scores each trading day, its expected return, the evidence for and against it, and whether the model portfolio holds it. The grades below describe the company's data; they are not the model's view.
See plans What's happening with CNC · updated 2026-10-05 · from prices and SEC filings Filed an 8-K on Sep 16 reporting investor presentation (Reg FD).Shares fell 5.5% over the past month , behind the S&P 500 (+0.4%) and behind its sector (-3.7%).CNC price performance CNC against the S&P 500, one year
+0% +50% +100% CNC +83% S&P 500 +18% 2025-09-29 2026-10-05 Year to date +56.3% S&P 500 +14.5% · ahead by 41.8 pts
1 year +66.1% S&P 500 +17.0% · ahead by 49.1 pts
3 years -6.8% S&P 500 +89.3% · behind by 96.1 pts
5 years +2.5% S&P 500 +91.3% · behind by 88.8 pts
Total returns with dividends reinvested.
CNC factor grades Each grade compares CNC with the rest of its sector (A+ best, F worst); the numbers behind it are shown with the typical figure for its peers.
– Value FCF yield 28.2% (sector 4.8%)
B- Growth Revenue growth +14% (sector +7%) EPS growth -355% (sector +12%)
D- Profitability Operating margin -2.8% (sector 14.1%) ROIC -30.7% (sector 10.8%)
B- Momentum 12-month change +66% From 52-wk high -7%
CNC in plain numbers Its free cash flow over the last 12 months equals 28.2% of its market value, higher than every other Health Care company Torvanta covers. Earnings per share fell 355% over the last 12 months, a bigger decline than every other Health Care company Torvanta covers. It earns -31% a year on the capital invested in the business, lower than 47 of the other 48 Health Care companies Torvanta covers. Its operating margin is -3% (operating profit per dollar of sales), lower than 49 of the other 51 Health Care companies Torvanta covers. CNC key statistics Sector Health Care
Industry Managed Health Care
Index S&P 500
Market value $31.8B
Revenue growth (y/y) +14%
Free-cash-flow yield 28.2%
Dividend yield n/a
Next earnings (expected) 2026-10-28
Valuation measures Market value $31.8B Enterprise value $23.7B Price / sales 0.2x Price / book 1.4x EV / revenue 0.1x
Financial highlights Revenue, last 12 months $202.9B Net income, last 12 months -$5.1B EPS, last 12 months (GAAP) $-10.44 Gross margin 8.0% Operating margin -2.8% Net margin -2.5% Return on equity -20.4% Return on invested capital -30.7% Cash $24.2B Total debt $16.1B Debt / equity 0.71x Free cash flow, last 12 months $9.0B Current ratio 1.15x
Company figures from its latest SEC filings; market value and returns from end-of-day prices.
CNC earnings trends Revenue vs earnings Quarterly Annual
-$6.6B $8.4B $23.5B $38.5B $53.6B Sep 2024 Revenue: $42.0B Dec 2024 Revenue: $40.8B Mar 2025 Revenue: $46.6B Jun 2025 Revenue: $48.7B Sep 2025 Revenue: $49.7B Dec 2025 Revenue: $49.7B Mar 2026 Revenue: $49.9B Jun 2026 Revenue: $53.6B Sep 2024 Net income: $713.0M Dec 2024 Net income: $283.0M Mar 2025 Net income: $1.3B Jun 2025 Net income: -$253.0M Sep 2025 Net income: -$6.6B Dec 2025 Net income: -$1.1B Mar 2026 Net income: $1.5B Jun 2026 Net income: $1.1B Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Net margin: 1.7% Net margin: 0.7% Net margin: 2.8% Net margin: -0.5% Net margin: -13.3% Net margin: -2.2% Net margin: 3.1% Net margin: 2.0% -13% -5% 3% ■ Revenue ■ Net income ━ Net margin -$6.7B $43.7B $94.1B $144.4B $194.8B FY2021 Revenue: $126.0B FY2022 Revenue: $144.5B FY2023 Revenue: $154.0B FY2024 Revenue: $163.1B FY2025 Revenue: $194.8B FY2021 Net income: $1.3B FY2022 Net income: $1.2B FY2023 Net income: $2.7B FY2024 Net income: $3.3B FY2025 Net income: -$6.7B FY2021 FY2022 FY2023 FY2024 FY2025 Net margin: 1.1% Net margin: 0.8% Net margin: 1.8% Net margin: 2.0% Net margin: -3.4% -3% -1% 2% ■ Revenue ■ Net income ━ Net margin Earnings per share $-13.5 $-9.4 $-5.2 $-1.0 $3.1 Sep 2024 EPS (GAAP, diluted): $1.4 Dec 2024 EPS (GAAP, diluted): $0.6 Mar 2025 EPS (GAAP, diluted): $2.6 Jun 2025 EPS (GAAP, diluted): $-0.5 Sep 2025 EPS (GAAP, diluted): $-13.5 Dec 2025 EPS (GAAP, diluted): $-2.2 Mar 2026 EPS (GAAP, diluted): $3.1 Jun 2026 EPS (GAAP, diluted): $2.2 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 ■ EPS (GAAP, diluted) Change from a year earlier: Sep 2025 -1093% · Dec 2025 -461% · Mar 2026 +18%
From the company's 10-Q and 10-K filings with the SEC.
Centene financials (from SEC filings) CNC earnings history Reported EPS (GAAP) EPS y/y Revenue y/y Stock vs S&P 500, 2 days 2026-07-28 $2.19 n/a +10% -2.2% 2026-04-28 $3.11 +18% +7% +24.6% 2026-02-06 $-2.24 -461% +22% -7.1% 2025-10-29 $-13.50 -1093% +18% +6.6% 2025-07-25 $-0.51 -124% +22% -0.0% 2025-07-01 $-0.51 -124% +22% -38.2%
About Centene Headquarters St Louis, MO
Industry (SEC code) Hospital & Medical Service Plans
Fiscal year ends December 31
Incorporated in DE
Listed on NYSE
From the company's SEC registration record.
Companies similar to CNC All Health Care stock ratings
Frequently asked questions Is CNC stock a buy? Torvanta does not tell individuals what to buy. Its grades for CNC are shown above. Subscribers see the model's rank, expected return and whether the model portfolio holds it. This is research, not a recommendation.
When does CNC report earnings next? Based on its filing history, Torvanta expects Centene to report around 2026-10-28.
How has CNC performed against the S&P 500? Over the past year CNC returned +66.1%, against +17.0% for the S&P 500, dividends reinvested.
See the model's view Subscribers get the model's rank and expected return for every covered company, the reasoning behind each, and the Torvanta model portfolio's trades each trading day, sized and explained, at three risk levels.
See plans Or get the free weekly newsletter Torvanta is research only - not investment advice and not a recommendation to buy or sell any security. Grades describe a company's reported data against its sector; they are not the model's view, change as data changes and can be wrong. Financial figures come from the company's SEC filings; returns include reinvested dividends. Past performance does not predict future results.
All stock ratings · Stock lists · AI stock research · Model portfolio · Research · Disclaimer